Certain Reduced Folate Nutraceutical Products and L-Methylfolate Raw Ingredients Used Therein; Institution of Investigation Pursuant to United States Code, 63336-63337 [2012-25378]

Download as PDF 63336 Federal Register / Vol. 77, No. 200 / Tuesday, October 16, 2012 / Notices duties, including whether the information is useful; (b) evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) enhance the quality, usefulness, and clarity of the information that ONRR collects; and (d) minimize the burden on the respondents, including the use of automated collection techniques or other forms of information technology. To comply with the public consultation process, we published a notice in the Federal Register on April 2, 2012 (77 FR 19704), announcing that we would submit this ICR to OMB for approval. The notice provided the required 60-day comment period. We received no unsolicited comments in response to the notice. If you wish to comment in response to this notice, you may send your comments to the offices listed under the ADDRESSES section of this notice. OMB has up to 60 days to approve or disapprove the information collection, but they may respond after 30 days. Therefore, in order to ensure maximum consideration, OMB should receive public comments by November 15, 2012. Public Comment Policy: We will post all comments, including names and addresses of respondents, at www.regulations.gov. Before including your address, phone number, e-mail address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us, in your comment, to withhold your personal identifying information from public view, we cannot guarantee that we will be able to do so. Information Collection Clearance Officer: Dave Alspach (202) 219–8526. Dated: October 2, 2012. Gregory J. Gould, Director, Office of Natural Resources Revenue. [FR Doc. 2012–25290 Filed 10–15–12; 8:45 am] tkelley on DSK3SPTVN1PROD with NOTICES BILLING CODE 4310–T2–C VerDate Mar<15>2010 16:06 Oct 15, 2012 Jkt 229001 INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–857] Certain Reduced Folate Nutraceutical Products and L-Methylfolate Raw Ingredients Used Therein; Institution of Investigation Pursuant to United States Code U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on September 10, 2012, under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of South Alabama Medical Science Foundation of Mobile, Alabama; Merck & Cie of Switzerland; and Pamlab LLC of Covington, Louisiana. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain reduced folate nutraceutical products and lmethylfolate raw ingredients used therein by reason of infringement of certain claims of U.S. Patent No. 5,997,915 (‘‘the ‘915 patent’’); U.S. Patent No. 6,673,381 (‘‘the ‘381 patent’’); U.S. Patent No. 7,172,778 (‘‘the ‘778 patent’’); and U.S. Patent No. 6,011,040 (‘‘the ‘040 patent’’). The complaint further alleges that an industry in the United States exists as required by subsection (a)(2) of section 337. The complainants request that the Commission institute an investigation and, after the investigation, issue an exclusion order and cease and desist orders. SUMMARY: The complaint, except for any confidential information contained therein, is available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Room 112, Washington, DC 20436, telephone (202) 205–2000. Hearing impaired individuals are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at (202) 205– 2000. General information concerning the Commission may also be obtained by accessing its internet server at http://www.usitc.gov. The public record for this investigation may be viewed on ADDRESSES: PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 the Commission’s electronic docket (EDIS) at http://edis.usitc.gov. FOR FURTHER INFORMATION CONTACT: The Office of the Secretary, Docket Services Division, U.S. International Trade Commission, telephone (202) 205–1802. Authority: The authority for institution of this investigation is contained in section 337 of the Tariff Act of 1930, as amended, and in section 210.10 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.10 (2012). Scope of Investigation: Having considered the complaint, the U.S. International Trade Commission, on October 10, 2012, ordered that— (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 1930, as amended, an investigation be instituted to determine whether there is a violation of subsection (a)(1)(B) of section 337 in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain reduced folate nutraceutical products and lmethylfolate raw ingredients used therein that infringe one or more of claims 37, 39, 40, 47, 66, 67, 73, 76, 78– 81, 83, 84, 86–89, 91, 92, 94–97, 99, 100, 110, 111, 113, 117, and 121 of the ‘915 patent; claims 22, 26, and 32–38 of the ‘381 patent; claims 1, 4–6, and 15 of the ‘778 patent; and claims 1–3, 5, 6, 8, 9, 11–15, and 19–22 of the ‘040 patent, and whether an industry in the United States exists as required by subsection (a)(2) of section 337. (2) For the purpose of the investigation so instituted, the following are hereby named as parties upon which this notice of investigation shall be served: (a) The complainants are: South Alabama Medical Science Foundation, 307 University Boulevard, PO Box U–1060, Mobile, AL 36688; Merck & Cie, Weisshausmatte, 6460 Altdorf, Switzerland; Pamlab LLC, 4099 Highway 190, Covington, LA 70433. (b) The respondents are the following entities alleged to be in violation of section 337, and are the parties upon which the complaint is to be served: Gnosis SpA, Via Lavoratori Autobianchi 1, 20832 Desio (MB), Italy; Gnosis Bioresearch SA, Via Lischedi, 4, 6592 Sant’Antonino, Switzerland; Gnosis USA Inc., 160 North Main Street, Doylestown, PA 18901; Macoven Pharmaceuticals LLC, 33219 Forest West Street, Magnolia, TX 77354. (3) For the investigation so instituted, the Chief Administrative Law Judge, U.S. International Trade Commission, E:\FR\FM\16OCN1.SGM 16OCN1 Federal Register / Vol. 77, No. 200 / Tuesday, October 16, 2012 / Notices shall designate the presiding Administrative Law Judge. The Office of Unfair Import Investigations will not participate as a party in this investigation. Responses to the complaint and the notice of investigation must be submitted by the named respondents in accordance with section 210.13 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.13. Pursuant to 19 CFR 201.16(d)–(e) and 210.13(a), such responses will be considered by the Commission if received not later than 20 days after the date of service by the Commission of the complaint and the notice of investigation. Extensions of time for submitting responses to the complaint and the notice of investigation will not be granted unless good cause therefor is shown. Failure of a respondent to file a timely response to each allegation in the complaint and in this notice may be deemed to constitute a waiver of the right to appear and contest the allegations of the complaint and this notice, and to authorize the administrative law judge and the Commission, without further notice to the respondent, to find the facts to be as alleged in the complaint and this notice and to enter an initial determination and a final determination containing such findings, and may result in the issuance of an exclusion order or a cease and desist order or both directed against the respondent. By order of the Commission. Issued: October 10, 2012. Lisa R. Barton, Acting Secretary to the Commission. BILLING CODE 7020–02–P JOINT BOARD FOR THE ENROLLMENT OF ACTUARIES Renewal of Charter of Advisory Committee on Actuarial Examinations Joint Board for the Enrollment of Actuaries. ACTION: Notice of Renewal of Advisory Committee. AGENCY: The Joint Board for the Enrollment of Actuaries announces the renewal of the charter of the Advisory Committee on Actuarial Examinations. FOR FURTHER INFORMATION CONTACT: Patrick McDonough, 202–622–8225. SUPPLEMENTARY INFORMATION: The purpose of the Advisory Committee on Examinations (Advisory Committee) is to advise the Joint Board for the Enrollment of Actuaries (Joint Board) on tkelley on DSK3SPTVN1PROD with NOTICES VerDate Mar<15>2010 17:25 Oct 15, 2012 Jkt 229001 Dated: October 9, 2012. David Ziegler, Chairman, Joint Board for the Enrollment of Actuaries. [FR Doc. 2012–25312 Filed 10–15–12; 8:45 am] BILLING CODE 4830–01–P DEPARTMENT OF JUSTICE [OMB Number 1122–0021] Agency Information Collection Activities: Extension of a Currently Approved Collection; Comments Requested; Semi-Annual Progress Report for the Grants To Enhance Culturally and Linguistically Specific Services for Victims of Domestic Violence, Dating Violence, Sexual Assault, and Stalking ACTION: [FR Doc. 2012–25378 Filed 10–15–12; 8:45 am] SUMMARY: examinations in actuarial mathematics and methodology. The Joint Board administers such examinations in discharging its statutory mandate to enroll individuals who wish to perform actuarial services with respect to pension plans subject to the Employee Retirement Income Security Act of 1974. The Advisory Committee’s functions include but, are necessarily limited to (1) considering and recommending examination topics; (2) developing examination questions; (3) recommending proposed examinations and pass marks; and (4) as requested by the Joint Board, making recommendations relative to the examination program. 30-Day Notice. The Department of Justice, Office on Violence Against Women (OVW) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register, Volume 77, Number 157, page 48539 on August 14, 2012, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until November 15, 2012. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 63337 Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–7285. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: SemiAnnual Progress Report for Grantees from Grants to Enhance Culturally and Linguistically Specific Services for Victims of Domestic Violence, Dating Violence, Sexual Assault, and Stalking Program (Culturally and Linguistically Specific Services Program). (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: 1122–0021. U.S. Department of Justice, Office on Violence Against Women. (4) Affected public who will be asked or required to respond, as well as a brief abstract: The affected public includes the approximately 50 grantees of the Culturally and Linguistically Specific Services Program. The program funds projects that promote the maintenance and replication of existing successful domestic violence, dating violence, sexual assault, and stalking communitybased programs providing culturally and linguistically specific services and other resources. The program also supports the development of innovative culturally and linguistically specific E:\FR\FM\16OCN1.SGM 16OCN1

Agencies

[Federal Register Volume 77, Number 200 (Tuesday, October 16, 2012)]
[Notices]
[Pages 63336-63337]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25378]


=======================================================================
-----------------------------------------------------------------------

 INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-857]


Certain Reduced Folate Nutraceutical Products and L-Methylfolate 
Raw Ingredients Used Therein; Institution of Investigation Pursuant to 
United States Code

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that a complaint was filed with the 
U.S. International Trade Commission on September 10, 2012, under 
section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on 
behalf of South Alabama Medical Science Foundation of Mobile, Alabama; 
Merck & Cie of Switzerland; and Pamlab LLC of Covington, Louisiana. The 
complaint alleges violations of section 337 based upon the importation 
into the United States, the sale for importation, and the sale within 
the United States after importation of certain reduced folate 
nutraceutical products and l-methylfolate raw ingredients used therein 
by reason of infringement of certain claims of U.S. Patent No. 
5,997,915 (``the `915 patent''); U.S. Patent No. 6,673,381 (``the `381 
patent''); U.S. Patent No. 7,172,778 (``the `778 patent''); and U.S. 
Patent No. 6,011,040 (``the `040 patent''). The complaint further 
alleges that an industry in the United States exists as required by 
subsection (a)(2) of section 337.
    The complainants request that the Commission institute an 
investigation and, after the investigation, issue an exclusion order 
and cease and desist orders.

ADDRESSES: The complaint, except for any confidential information 
contained therein, is available for inspection during official business 
hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW., Room 112, Washington, 
DC 20436, telephone (202) 205-2000. Hearing impaired individuals are 
advised that information on this matter can be obtained by contacting 
the Commission's TDD terminal on (202) 205-1810. Persons with mobility 
impairments who will need special assistance in gaining access to the 
Commission should contact the Office of the Secretary at (202) 205-
2000. General information concerning the Commission may also be 
obtained by accessing its internet server at http://www.usitc.gov. The 
public record for this investigation may be viewed on the Commission's 
electronic docket (EDIS) at http://edis.usitc.gov.

FOR FURTHER INFORMATION CONTACT: The Office of the Secretary, Docket 
Services Division, U.S. International Trade Commission, telephone (202) 
205-1802.

    Authority: The authority for institution of this investigation 
is contained in section 337 of the Tariff Act of 1930, as amended, 
and in section 210.10 of the Commission's Rules of Practice and 
Procedure, 19 CFR 210.10 (2012).
    Scope of Investigation: Having considered the complaint, the U.S. 
International Trade Commission, on October 10, 2012, ordered that--
    (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 
1930, as amended, an investigation be instituted to determine whether 
there is a violation of subsection (a)(1)(B) of section 337 in the 
importation into the United States, the sale for importation, or the 
sale within the United States after importation of certain reduced 
folate nutraceutical products and l-methylfolate raw ingredients used 
therein that infringe one or more of claims 37, 39, 40, 47, 66, 67, 73, 
76, 78-81, 83, 84, 86-89, 91, 92, 94-97, 99, 100, 110, 111, 113, 117, 
and 121 of the `915 patent; claims 22, 26, and 32-38 of the `381 
patent; claims 1, 4-6, and 15 of the `778 patent; and claims 1-3, 5, 6, 
8, 9, 11-15, and 19-22 of the `040 patent, and whether an industry in 
the United States exists as required by subsection (a)(2) of section 
337.
    (2) For the purpose of the investigation so instituted, the 
following are hereby named as parties upon which this notice of 
investigation shall be served:
    (a) The complainants are:

South Alabama Medical Science Foundation, 307 University Boulevard, PO 
Box U-1060, Mobile, AL 36688;
Merck & Cie, Weisshausmatte, 6460 Altdorf, Switzerland;
Pamlab LLC, 4099 Highway 190, Covington, LA 70433.

    (b) The respondents are the following entities alleged to be in 
violation of section 337, and are the parties upon which the complaint 
is to be served:

Gnosis SpA, Via Lavoratori Autobianchi 1, 20832 Desio (MB), Italy;
Gnosis Bioresearch SA, Via Lischedi, 4, 6592 Sant'Antonino, 
Switzerland;
Gnosis USA Inc., 160 North Main Street, Doylestown, PA 18901;
Macoven Pharmaceuticals LLC, 33219 Forest West Street, Magnolia, TX 
77354.

    (3) For the investigation so instituted, the Chief Administrative 
Law Judge, U.S. International Trade Commission,

[[Page 63337]]

shall designate the presiding Administrative Law Judge.
    The Office of Unfair Import Investigations will not participate as 
a party in this investigation.
    Responses to the complaint and the notice of investigation must be 
submitted by the named respondents in accordance with section 210.13 of 
the Commission's Rules of Practice and Procedure, 19 CFR 210.13. 
Pursuant to 19 CFR 201.16(d)-(e) and 210.13(a), such responses will be 
considered by the Commission if received not later than 20 days after 
the date of service by the Commission of the complaint and the notice 
of investigation. Extensions of time for submitting responses to the 
complaint and the notice of investigation will not be granted unless 
good cause therefor is shown.
    Failure of a respondent to file a timely response to each 
allegation in the complaint and in this notice may be deemed to 
constitute a waiver of the right to appear and contest the allegations 
of the complaint and this notice, and to authorize the administrative 
law judge and the Commission, without further notice to the respondent, 
to find the facts to be as alleged in the complaint and this notice and 
to enter an initial determination and a final determination containing 
such findings, and may result in the issuance of an exclusion order or 
a cease and desist order or both directed against the respondent.

    By order of the Commission.

    Issued: October 10, 2012.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2012-25378 Filed 10-15-12; 8:45 am]
BILLING CODE 7020-02-P